Belgium vs Czechia: Communicable diseases — Communicable disease incidence
Belgium
64 Cases
in 2024
Czechia
63 Cases
in 2024
Belgium rank
20th
Czechia rank
21st
Communicable diseases — Communicable disease incidence over time
- Belgium
- Czechia
How they compare
Belgium currently reports 64 Cases against 63 Cases in Czechia, a difference of 1 Cases.
Across all 44 years both countries report, Belgium has been ahead every year.
Belgium ranks 20th and Czechia ranks 21st of 34 countries.
Belgium has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Belgium | Czechia | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 75.11 Cases | 1.78 Cases | 73.33 Cases | Belgium |
| 1990s | 209.1 Cases | 12 Cases | 197.1 Cases | Belgium |
| 2000s | 134.5 Cases | 16.7 Cases | 117.8 Cases | Belgium |
| 2010s | 97.3 Cases | 37.4 Cases | 59.9 Cases | Belgium |
| 2020s | 77.8 Cases | 61.6 Cases | 16.2 Cases | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Belgium or Czechia?
- Belgium, at 64 Cases against 63 Cases in Czechia as of 2024.
- What is the difference in communicable diseases — communicable disease incidence between Belgium and Czechia?
- 1 Cases, with Belgium ahead.
- How many years of comparable data are there for Belgium and Czechia?
- 44 years are reported by both, from 1981 to 2024.
- How do Belgium and Czechia rank globally for communicable diseases — communicable disease incidence?
- Belgium ranks 20th and Czechia ranks 21st of 34 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.